Biotricity Brings Together Industry Experts to Advise on Post-Diagnostic Cardiac Care
May 09, 2017 12:02 pm UTC| Business
REDWOOD CITY, Calif., May 09, 2017 -- Biotricity, Inc.(OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring solutions, has...
Thermon Schedules Fourth Quarter and Full Fiscal 2017 Earnings Conference Call – May 24, 2017
May 09, 2017 12:02 pm UTC| Business
SAN MARCOS, Texas, May 09, 2017 -- Thermon Group Holdings, Inc. (NYSE:THR) (“Thermon”) will issue a press release reporting its consolidated financial results for the fourth quarter and full fiscal year ended March 31,...
May 09, 2017 12:02 pm UTC| Business
Shapleigh, ME , May 09, 2017 -- Families for Treatment of Serious Mental Illness (TreatSMI), a nonprofit organization focused on advocacy, support and education for the seriously mentally ill and their family...
Okta Announces Date for its First Quarter Fiscal 2018 Financial Results
May 09, 2017 12:01 pm UTC| Business
SAN FRANCISCO, May 09, 2017 -- Okta, Inc. (NASDAQ:OKTA) the leading independent provider of identity for the enterprise, today announced that it will release its financial results for its first quarter of fiscal year...
Delcath Announces First Quarter 2017 Financial Results
May 09, 2017 12:01 pm UTC| Business
NEW YORK, May 09, 2017 -- Delcath Systems, Inc. (NASDAQ:DCTH), an interventional oncology Company focused on the treatment of primary and metastatic liver cancers, announces financial results for the three months ended...
Jounce Therapeutics Reports First Quarter 2017 Financial Results
May 09, 2017 12:01 pm UTC| Business
- Completed upsized initial public offering raising $117.1 million in gross proceeds -- Presented preclinical data supporting ongoing Phase 1/2 ICONIC study -- Initiated Phase 2 portion of ICONIC study evaluating JTX-2011...
Jounce Therapeutics Reports First Quarter 2017 Financial Results
May 09, 2017 12:01 pm UTC| Business
- Completed upsized initial public offering raising $117.1 million in gross proceeds -- Presented preclinical data supporting ongoing Phase 1/2 ICONIC study -- Initiated Phase 2 portion of ICONIC study evaluating JTX-2011...
Threading Opportunity: How an India–EU FTA Could Reweave Textile Fortunes